Inogen (INGN) Cash from Investing Activities (2013 - 2026)
Inogen (INGN) posted quarterly Cash from Investing Activities of -$2.0 million for Q1 2026, up 3.09% year-over-year from -$1.9 million in Q1 2025, and down 30.28% quarter-over-quarter from -$1.5 million in Q4 2025.
Inogen (INGN) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Cash from Investing Activities for 14 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 3.09% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$26.1 million (down 917.75% YoY), while the FY2025 annual figure was -$26.2 million, down 87.54% from the prior year.
- Cash from Investing Activities eased to -$2.0 million in Q1 2026 per INGN's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $11.5 million in Q4 2024 and bottomed at -$45.8 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$6.6 million across 5 years, with a median of -$2.0 million in 2025.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 210.57% — and 2024, when it tumbled 2191.85%.
- Inogen's Cash from Investing Activities stood at -$6.9 million in 2022, then surged by 159.45% to $4.1 million in 2023, then surged by 179.55% to $11.5 million in 2024, then tumbled by 113.14% to -$1.5 million in 2025, then sank by 30.28% to -$2.0 million in 2026.
- Business Quant data shows INGN's Cash from Investing Activities at -$2.0 million in Q1 2026, -$1.5 million in Q4 2025, and -$82000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Inogen | 152.26 Mn | 46.72 Mn | 43.27 Mn | -3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.13 Mn |
| Jun 30, 2026 | -3.13 Mn |
| Mar 31, 2026 | -1.98 Mn |
| Mar 31, 2026 | -1.98 Mn |
| Dec 31, 2025 | -1.52 Mn |
| Dec 31, 2025 | -1.52 Mn |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | -22.57 Mn |
| Jun 30, 2025 | -22.57 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | 11.54 Mn |
| Dec 31, 2024 | 11.54 Mn |
| Sep 30, 2024 | 305,000.00 |
| Sep 30, 2024 | 305,000.00 |
| Jun 30, 2024 | -12.38 Mn |
| Jun 30, 2024 | -12.38 Mn |
| Mar 31, 2024 | -13.44 Mn |
| Mar 31, 2024 | -13.44 Mn |